HIV and interferon regulatory factor 1: A story of manipulation and control

AIDS Research and Human Retroviruses

Volumn 29, Issue 11, 2013, Pages 1428-1433

  Sivro, Aida ^a   Su, Ruey Chyi ^a   Plummer, Francis A ^a   Ball, T Blake ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INTERFERON REGULATORY FACTOR 1;

DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LATENT PERIOD; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERON REGULATORY FACTOR-1; VIRUS REPLICATION;

EID: 84886648229     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0098     Document Type: Review

References (52)

1. McMichael AJ and Haynes BF: Lessons learned from HIV-1 vaccine trials: New priorities and directions. Nat Immunol 2012; 13: 423-427.
2. Walker BD and Burton DR: Toward an AIDS vaccine. Science 2008; 320: 760-764.
3. Kirchhoff F: Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 2010; 8: 55-67.
4. Pinney JW, Dickerson JE, Fu W, Sanders-Beer BE, Ptak RG, and Robertson DL: HIV-host interactions: A map of viral perturbation of the host system. AIDS 2009; 23: 1.
5. Nehyba J, Hrdlicková R, and Bose HR: Dynamic evolution of immune system regulators: The history of the interferon regulatory factor family. Mol Biol Evol 2009; 26: 2539-2550.
6. Nehyba J, Hrdlicková R, and Bose HR Jr: Evolution of the Interferon Regulatory Factor Family. John Wiley & Sons, Ltd., Chichester, UK, 2001.
7. Huang B, Qi ZT, Xu Z, and Nie P: Global characterization of interferon regulatory factor (IRF) genes in vertebrates: Glimpse of the diversification in evolution. BMC Immunol 2010; 11: 22.
8. Marsili G, Borsetti A, and Sgarbanti M: On the role of interferon regulatory factors in HIV-1 replication. Ann NY Acad Sci 2003; 1010: 29-42.
9. Mamane Y, Heylbroeck C, Génin P, Algarté M, Servant MJ, LePage C, et al.: Interferon regulatory factors: The next generation. Gene 1999; 237: 1-14.
10. Fujita J, Sakakibara J, Sudo Y, et al.: Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J 1988; 7: 3397.
11. Liang C, Li X, Quan Y, Laughrea M, Kleiman L, Hiscott J, et al.: Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription. J Mol Biol 1997; 272: 167-177.
12. Alcamí J, Lain de Lera T, Folgueira L, et al.: Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 1995; 14: 1552.
13. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, et al.: Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989; 58: 729-739.
14. Thornton AM, Buller RM, DeVico AL, Wang IM, and Ozato K: Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells. Proc Natl Acad Sci USA 1996; 93: 383-387.
15. Harman AN, Lai J, Turville S, Samarajiwa S, Gray L, Marsden V, et al.: HIV infection of dendritic cells subverts the interferon induction pathway via IRF1 and inhibits type 1 interferon production. Blood 2011; 118: 298-308.
16. Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, Nappi F, et al.: Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med 2002; 195: 1359-1370.
17. Sgarbanti M, Marsili G, Remoli AL, Ridolfi B, Stellacci E, Borsetti A, et al.: Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation. Ann NY Acad Sci 2004; 1030: 187-195.
18. Nasr N, Maddocks S, Turville SG, Harman AN, Woolger N, Helbig KJ, et al.: HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 2012; 120: 778-788.
19. Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E, et al.: IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J Virol 2008; 82: 3632-3641.
20. Horton RE, McLaren PJ, Fowke K, Kimani J, and Ball TB: Cohorts for the study of HIV-1-exposed but uninfected individuals: Benefits and limitations. J Infect Dis 2010; 202: S377-S381.
21. Lederman MM, Alter G, Daskalakis DC, Rodríguez B, Sieg SF, Hardy G, et al.: Determinants of protection among HIVexposed seronegative persons: An overview. J Infect Dis 2010; 202: S333-338.
22. Tomescu C, Abdulhaqq S, and Montaner LJ: Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clin Exp Immunol 2011; 164: 158-169.
23. Ji H, Ball TB, Kimani J, and Plummer FA: Novel interferon regulatory factor-1 polymorphisms in a Kenyan population revealed by complete gene sequencing. J Hum Genet 2004; 49: 528-535.
24. Ball T, Ji H, Kimani J, McLaren P, Marlin C, Hill A, et al.: Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 2007; 21: 1091.
25. Ji H, Ball TB, Ao Z, Kimani J, Yao X, and Plummer FA: Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: A potential mechanism mediating resistance to infection by HIV-1. Scand J Infect Dis 2010; 42: 389-394.
26. Sivro A, McKinnon LR, Ji H, Kimani J, Jaoko W, Plummer FA, et al.: Interferon regulatory factor 1 polymorphisms previously associated with reduced HIV susceptibility have no effect on HIV disease progression. PLoS One 2013; 8: e66253.
27. Su R-C, Sivro A, Kimani J, Jaoko W, Plummer FA, and Ball TB: Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals. Blood 2011; 117: 2649-2657.
28. Margolis DM: Mechanisms of HIV latency: An emerging picture of complexity. Curr HIV/AIDS Rep 2010; 7: 37-43.
29. Joos B, Fischer M, Kuster H, Pillai SK, Wong JK, Boni J, et al.: HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc Natl Acad Sci USA 2008; 105: 16725-16730.
30. Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, et al.: Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4 + T cells. Nat Med 2003; 9: 727-728.
31. Williams SAF and Greene WC: Host factors regulating postintegration latency of HIV. Trends Microbiol 2005; 13: 137-139.
32. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278: 1295-1300.
33. Wong JK: Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278: 1291-1295.
34. Nelson N, Kanno Y, Hong C, Contursi C, Fujita T, Fowlkes BJ, et al.: Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. J Immunol 1996; 156: 3711-3720.
35. Oeckinghaus A and Ghosh S: The NF- B family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009; 1: a000034.
36. Taniguchi T, Ogasawara K, Takaoka A, and Tanaka N: IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623-655.
37. Munier S, Delcroix-Genete D, Carthagéna L, Gumez A, and Hazan U: Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency. Retrovirology 2005; 2: 73.
38. Kroger A, Koster M, Schroeder K, Hauser H, and Mueller PP: Review: Activities of IRF-1. J Interferon Cytokine Res 2002; 22: 5-14.
39. Gabriele L, Fragale A, Borghi P, Sestili P, Stellacci E, Venditti M, et al.: IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features. J Leukoc Biol 2006; 80: 1500-1511.
40. Piacentini L, Fenizia C, Naddeo V, and Clerici M: Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine 2008; 26: 3002-3007.
41. Samarajiwa SA, Forster S, Auchettl K, and Hertzog PJ: INTERFEROME: The database of interferon regulated genes. Nucleic Acids Res 2009; 37: D852-857.
42. Hou W, Wang X, Ye L, Zhou L, Yang Z-Q, Riedel E, et al.: Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J Virol 2009; 83: 3834-3842.
43. Shirazi Y and Pitha PM: Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 1993; 193: 303-312.
44. Michaelis B and Levy JA: HIV replication can be blocked by recombinant human interferon beta. AIDS 1989; 3: 27-31.
45. Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464: 217-223.
46. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, and Haynes BF: The immune response during acute HIV-1 infection: Clues for vaccine development. Nat Rev Immunol 2009; 10: 11-23.
47. Boasso A and Shearer GM: Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008; 126: 235-242.
48. Huigen M, Kamp W, and Nottet H: Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur J Clin Invest 2004; 34: 57-66.
49. Remoli AL, Marsili G, Perrotti E, Gallerani E, Ilari R, Nappi F, et al.: Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. Biochem J 2006; 396: 371-380.
50. Badley AD, Pilon AA, Landay A, and Lynch DH: Mechanisms of HIV-associated lymphocyte apoptosis. Blood 2000; 96: 2951-2964.
51. Chow WA, Fang JJ, and Yee J-K: The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J Immunol 2000; 164: 3512-3518.
52. Castaldello A, Sgarbanti M, and Marsili G: Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination. J Cell Physiol 2010; 224: 702-709.